Literature DB >> 23582965

The potential of non-invasive ventilation to decrease BPD.

Vineet Bhandari1.   

Abstract

Bronchopulmonary dysplasia (BPD), the most common chronic lung disease in infancy, has serious long-term pulmonary and neurodevelopmental consequences right up to adulthood, and is associated with significant healthcare costs. BPD is a multifactorial disease, with genetic and environmental factors interacting to culminate in the characteristic clinical and pathological phenotype. Among the environmental factors, invasive endotracheal tube ventilation is considered a critical contributing factor to the pathogenesis of BPD. Since BPD currently has no specific preventive or effective therapy, considerable interest has focused on the use of non-invasive ventilation as a means to potentially decrease the incidence of BPD. This article reviews the progress made in the last 5 years in the use of nasal continuous positive airways pressure (NCPAP) and nasal intermittent positive pressure ventilation (NIPPV) as it pertains to impacting on BPD rates. Research efforts are summarized, and some guidelines are suggested for clinical use of these techniques in neonates.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23582965     DOI: 10.1053/j.semperi.2013.01.007

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  18 in total

1.  Neonatal nasal intermittent positive pressure ventilation efficacy and lung pressure transmission.

Authors:  A Mukerji; J Belik
Journal:  J Perinatol       Date:  2015-06-04       Impact factor: 2.521

2.  Surfactant utilization and short-term outcomes in an era of non-invasive respiratory support in Canadian neonatal intensive care units.

Authors:  K Raghuram; A Mukerji; J Young; W Yee; M Seshia; K Dow; V Shah
Journal:  J Perinatol       Date:  2017-06-29       Impact factor: 2.521

3.  Factors affecting nasal intermittent positive pressure ventilation failure and impact on bronchopulmonary dysplasia in neonates.

Authors:  P Mehta; J Berger; E Bucholz; V Bhandari
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

Review 4.  Weaning of nasal CPAP in preterm infants: who, when and how? a systematic review of the literature.

Authors:  Shaili Amatya; Deepa Rastogi; Alok Bhutada; Shantanu Rastogi
Journal:  World J Pediatr       Date:  2014-12-29       Impact factor: 2.764

5.  Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia.

Authors:  Alida S D Kindt; Kai M Förster; Suzan C M Cochius-den Otter; Andreas W Flemmer; Stefanie M Hauck; Andrew Flatley; Juliette Kamphuis; Stefan Karrasch; Jürgen Behr; Axel Franz; Christoph Härtel; Jan Krumsiek; Dick Tibboel; Anne Hilgendorff
Journal:  Pediatr Res       Date:  2022-05-20       Impact factor: 3.756

6.  Evaluation of a practice guideline for the management of respiratory distress syndrome in preterm infants: A quality improvement initiative.

Authors:  Brooke Read; David Sc Lee; Debbie Fraser
Journal:  Paediatr Child Health       Date:  2016 Jan-Feb       Impact factor: 2.253

Review 7.  Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach.

Authors:  Aaron Hamvas; Gloria S Pryhuber; Nathalie L Maitre; Roberta A Ballard; Jonas H Ellenberg; Stephanie D Davis; James M Greenberg
Journal:  J Perinatol       Date:  2015-03-26       Impact factor: 2.521

8.  Drug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targets.

Authors:  Vineet Bhandari
Journal:  Front Pediatr       Date:  2014-07-25       Impact factor: 3.418

9.  Non-invasive duo positive airway pressure ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: a randomized controlled trial.

Authors:  Arash Malakian; Mohammad Reza Aramesh; Mina Agahin; Masoud Dehdashtian
Journal:  BMC Pediatr       Date:  2021-07-06       Impact factor: 2.125

10.  Need for supplemental oxygen at discharge in infants with bronchopulmonary dysplasia is not associated with worse neurodevelopmental outcomes at 3 years corrected age.

Authors:  Abhay Lodha; Reg Sauvé; Vineet Bhandari; Selphee Tang; Heather Christianson; Anita Bhandari; Harish Amin; Nalini Singhal
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.